Impact of adjuvant sorafenib treatment after local ablation for HCC in the phase II SORAMIC trial

BACKGROUND & AIMS: The aim of the study was to evaluate the efficacy and safety of adjuvant sorafenib treatment compared with placebo in patients with hepatocellular carcinoma who underwent local ablation. METHODS: The SORAMIC trial is a randomised controlled trial with diagnostic, local ablatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Seidensticker, Max, Öcal, Osman, Schütte, Kerstin, Malfertheiner, Peter, Berg, Thomas, Loewe, Christian, Klümpen, Heinz Josef, van Delden, Otto, Ümütlü, Muzaffer Reha, Ben Khaled, Najib, de Toni, Enrico Narciso, Seidensticker, Ricarda, Aghdassi, Ali, Tran, Albert, Bronowicki, Jean-Pierre, Peynircioglu, Bora, Sangro, Bruno, Pech, Maciej, Ricke, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031000/
https://www.ncbi.nlm.nih.gov/pubmed/36968218
http://dx.doi.org/10.1016/j.jhepr.2023.100699

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031000/
https://www.ncbi.nlm.nih.gov/pubmed/36968218
http://dx.doi.org/10.1016/j.jhepr.2023.100699

Ejemplares similares